ENTITY

China NT Pharma Group (1011 HK)

8
Analysis
Health Care • Hong Kong
China NT Pharma Group is a technology-based pharmaceutical company engaged in the research, development, manufacturing, sales, and distribution of pharmaceutical products, including prescription medications across various therapeutic areas like oncology, orthopedics, and neurology. The company also provides pharmaceutical marketing, promotion, and supply chain services, and operates through digital services and sales agency segments, with a recent pivot towards an AI healthcare platform. Founded in 1995, the company is headquartered in Central, Hong Kong.
more
bullish•Manycore Tech
•21 Jul 2026 16:48

HSCI / HK Connect Sep 2026 Rebalance Forecast

We forecast 44 ADD candidates and 26 DELETE candidates for the HSCI September review, with the announcement expected on 21 Aug 2026.

Logo
182 Views
Share
•16 Jul 2026 17:40

HK IPO 2Q2026 Essential Analytics: Record Demand, Faster Fade

We review 32 HK IPOs above US$100m in 2Q26 against the six-quarter history since 1Q25. Record subscription demand met a faster post-debut fade,...

Logo
138 Views
Share
x